Fatty liver in familial hypobetalipoproteinemia: triglyceride assembly into VLDL particles is affected by the extent of hepatic steatosis.
about
Molecular biology of PCSK9: its role in LDL metabolismFamilial hypobetalipoproteinemia: a reviewExome sequencing, ANGPTL3 mutations, and familial combined hypolipidemiaReduced intestinal fat absorptive capacity but enhanced susceptibility to diet-induced fatty liver in mice heterozygous for ApoB38.9 truncationA targeted apoB38.9 mutation in mice is associated with reduced hepatic cholesterol synthesis and enhanced lipid peroxidationHepatic secretion of apoB-100 is impaired in hypobetalipoproteinemic mice with an apoB-38.9-specifying alleleIn vivo MRS measurement of liver lipid levels in mice.Quantitative study of liver magnetic resonance spectroscopy quality at 3T using body and phased array coils with physical analysis and clinical evaluationComparative MR study of hepatic fat quantification using single-voxel proton spectroscopy, two-point dixon and three-point IDEAL.Identification of novel molecular candidates for fatty liver in the hyperlipidemic mouse model, HcB19.Mutations in the ANGPTL3 gene and familial combined hypolipidemia: a clinical and biochemical characterization.Effect of apolipoprotein-B synthesis inhibition on liver triglyceride content in patients with familial hypercholesterolemia.Lipoproteins: When size really matters.Dissociation between intrahepatic triglyceride content and insulin resistance in familial hypobetalipoproteinemia.Peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) stimulates VLDL assembly through activation of cell death-inducing DFFA-like effector B (CideB)Short locked nucleic acid antisense oligonucleotides potently reduce apolipoprotein B mRNA and serum cholesterol in mice and non-human primatesA spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol.Exercise training augments the peripheral insulin-sensitizing effects of pioglitazone in HIV-infected adults with insulin resistance and central adiposity.Metabolic pathways promoting intrahepatic fatty acid accumulation in methionine and choline deficiency: implications for the pathogenesis of steatohepatitisGenetic determinants of hepatic steatosis in man.Whole-body proteolysis rate is elevated in HIV-associated insulin resistance.Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study.Hepatocyte-Specific Depletion of UBXD8 Induces Periportal Steatosis in Mice Fed a High-Fat DietHypobetalipoproteinemia and abetalipoproteinemia.Hepatic Steatosis as a Marker of Metabolic Dysfunction.Familial hypobetalipoproteinemia-induced nonalcoholic steatohepatitisMonogenic hypocholesterolaemic lipid disorders and apolipoprotein B metabolism.Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implicationsClinical utility gene card for: Familial hypobetalipoproteinaemia (APOB)--Update 2014.Common and rare gene variants affecting plasma LDL cholesterolFatty liver and insulin resistance: not always linked.Clinical characteristics and plasma lipids in subjects with familial combined hypolipidemia: a pooled analysis.A novel APOB mutation identified by exome sequencing cosegregates with steatosis, liver cancer, and hypocholesterolemia.Diet and exercise interventions reduce intrahepatic fat content and improve insulin sensitivity in obese older adults.Anti-PCSK9 therapies for the treatment of hypercholesterolemia.Efficacy and safety of mipomersen sodium (Kynamro).Steatosis in the liver.Update on primary hypobetalipoproteinemia.Insights from human congenital disorders of intestinal lipid metabolism.Inhibitory effect of Ginkgo biloba extract on fatty liver: regulation of carnitine palmitoyltransferase 1a and fatty acid metabolism.
P2860
Q27488922-35973073-FA3D-4E96-A964-F5953ED434E9Q28183795-A2C99329-6BA6-4959-A5D2-44D35B6F79A5Q28295479-B519CE26-5692-4459-9215-7C51BB775415Q28508454-717ACDBC-7F01-4AD2-8053-A3D1E0641A6AQ28585589-A4EA9A99-C139-46E9-8052-3C747BFA70D6Q28593031-621EDC7A-C310-4514-AB20-F48F2BBAE54CQ30924323-1A90D04D-7956-4035-9D7C-AB0D2E3E6146Q30934274-BCB6E745-BE88-4625-BC62-C9D07635E368Q31147984-9244959A-D550-4C88-801B-58426429A2D8Q33200804-865D64E3-82D1-4F4D-8B16-AE14F2B54935Q33569939-D25CC328-072C-4AAF-953F-0009281418A3Q33784492-D6BC48F0-43BE-4CEA-9EDD-6823149C8AEAQ33947533-C9D83914-E7E5-47EC-BE1D-C8DBB8532178Q33987896-E85D9F83-671D-4638-BAF8-0E5683272C72Q34074263-E9FF1F8C-B70F-4E5C-A99B-35E0D94AD368Q34298059-45AEED10-0690-4BFC-8D7F-F1590B317475Q34399014-835C6106-295F-4F7F-A880-569F9E86237CQ34501780-BCEEED16-8C5A-4AE0-AD74-2F9BE2AF1B0EQ34597471-49E01971-DB24-46F5-A938-423148CDF9EDQ34646183-160E69FE-A597-4D43-82F4-2BFE2FDBA95AQ35575238-8EA73B4D-DBB7-4BF8-86E8-FB9ACA7A1932Q35597166-AA41B855-9A7D-4F2E-BE44-59EF371FF510Q35602046-60DF1902-B755-4E61-B6D1-B8468860B9ECQ35738368-005DEF09-D5FA-44F4-91CB-FBABEA12AF11Q35809069-93EFE937-EF0D-4C25-9F0A-3EC21E639D07Q36098448-3AA16683-D229-4433-B723-AD35F9F3D330Q36359516-795D1734-43BC-42D5-B5E6-88C6D7ECE8D4Q36617551-4DFB1597-E890-4A1A-B1B4-B43D0E1C8C1EQ36695217-BC1A033A-F98B-49CF-AF6D-9701DE2A49D9Q36711327-E3024263-D664-4E95-A055-78AF5EC95499Q36742407-2AD8DE23-0AEA-4C99-9337-ECC6E3442B92Q37305417-3CCCCDE3-96D7-4A1D-8ADD-45B17DB228DAQ37408477-69B5F758-71FB-4B3C-8722-8F406E209972Q37475764-543A9A43-5053-40E1-A70B-8549233A0A3BQ38067460-AF180CFC-1E07-47A4-992D-1F6C89B12660Q38101125-AB2CD487-39EC-4053-8768-A740402A7F09Q38165140-2AE999B6-25BA-4DFA-9FCC-53CB8832C15FQ38208223-3AEF788E-2C0E-4DF2-850C-D75D5187DEA6Q38267212-B90737F8-1ACD-446E-AA74-20BE819CF3E1Q39276367-24B53FCC-79B1-4700-AB0D-0F2345549C71
P2860
Fatty liver in familial hypobetalipoproteinemia: triglyceride assembly into VLDL particles is affected by the extent of hepatic steatosis.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Fatty liver in familial hypobe ...... e extent of hepatic steatosis.
@en
Fatty liver in familial hypobe ...... e extent of hepatic steatosis.
@nl
type
label
Fatty liver in familial hypobe ...... e extent of hepatic steatosis.
@en
Fatty liver in familial hypobe ...... e extent of hepatic steatosis.
@nl
prefLabel
Fatty liver in familial hypobe ...... e extent of hepatic steatosis.
@en
Fatty liver in familial hypobe ...... e extent of hepatic steatosis.
@nl
P2093
P2860
P50
P1476
Fatty liver in familial hypobe ...... he extent of hepatic steatosis
@en
P2093
Gustav Schonfeld
Joseph Ackerman
Nizar Elias
Tariq S K Tanoli
P2860
P304
P356
10.1194/JLR.M200342-JLR200
P577
2002-12-01T00:00:00Z